Focusfreda Wins European International Patent, Pioneering New Frontier in Sodium Hyaluronate Technology
Recently, Focusfreda secured another European international patent for PREPARATION METHOD FOR ACETYLATED SODIUM HYALURONATE, a certification that not only underscores the company's technological leadership in sodium hyaluronate derivative research but also reaffirms its innovative capabilities with international recognition. This breakthrough provides critical technological backing for strengthening brand influence and expanding global markets.
As an upgraded modification of conventional sodium hyaluronate, acetylated sodium hyaluronate retains superior moisturizing properties while optimizing molecular structure through acetyl group introduction. This enhancement improves both hydrophilicity and lipophilicity, delivering a fresh, non-sticky texture with long-lasting hydration. It also demonstrates exceptional skin barrier repair capabilities, effectively improving skin elasticity and maintaining smooth texture.
The successful authorization of this European patent marks a milestone in the company's ongoing intellectual property strategy and serves as a strategic pillar for building a global IP system. Moving forward, Focusfreda will continue leveraging patent strategies to establish technological barriers, empowering industrial upgrades through proprietary innovations. By forging an internationally robust patent portfolio in sodium hyaluronate, the company aims to deliver strong technological support for global markets.
RECOMMENDED READING
CONTACT US
Tel：+86-0537-3195566
E-mail：sales@focuschem.com
Add：Economic Development Zone, High-speed Railway New District, Qufu City, Jining City, Shandong Province, China
Copyright © 2022 Shandong Focusfreda Biotech Co., Ltd. 鲁ICP备2021008509号-2 Powerby : 300.cn jinan SEO